Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast BT12 6BA, UK.
Int J Environ Res Public Health. 2022 Oct 25;19(21):13861. doi: 10.3390/ijerph192113861.
People who have experienced a stroke or transient ischaemic attack (TIA) have greater risks of complications from COVID-19. Therefore, vaccine uptake in this vulnerable population is important. To prevent vaccine hesitancy and maximise compliance, we need to better understand individuals' views on the vaccine.
We aimed to explore perspectives of the COVID-19 vaccine and influences on its uptake from people who have experienced a stroke or TIA.
A cross-sectional, electronic survey comprising multiple choice and free text questions. Convenience sampling was used to recruit people who have experienced a stroke/TIA in the UK/Ireland.
The survey was completed by 377 stroke/TIA survivors. 87% (328/377) had either received the first vaccine dose or were booked to have it. The vaccine was declined by 2% (7/377) and 3% (11/377) had been offered the vaccine but not yet taken it up. 8% (30/377) had not been offered the vaccine despite being eligible. Some people expressed concerns around the safety of the vaccine (particularly risk of blood clots and stroke) and some were hesitant to have the second vaccine. Societal and personal benefits were motivations for vaccine uptake. There was uncertainty and lack of information about risk of COVID-19 related complications specifically for people who have experienced a stroke or TIA.
Despite high uptake of the first vaccine, some people with stroke and TIA have legitimate concerns and information needs that should be addressed. Our findings can be used to identify targets for behaviour change to improve vaccine uptake specific to stroke/TIA patients.
经历过中风或短暂性脑缺血发作（TIA）的人患 COVID-19 并发症的风险更高。因此，为了防止疫苗犹豫并最大限度地提高接种率，我们需要更好地了解个人对疫苗的看法。
我们旨在探讨经历过中风或 TIA 的人对 COVID-19 疫苗的看法及其对疫苗接种的影响。
采用横断面、电子调查，包括多项选择和自由文本问题。采用方便抽样法招募英国/爱尔兰的中风/TIA 患者。
共有 377 名中风/TIA 幸存者完成了调查。87%（328/377）已经接种了第一剂疫苗或已预约接种。2%（7/377）拒绝接种疫苗，3%（11/377）已预约但尚未接种。尽管有资格接种，但 8%（30/377）尚未接种疫苗。一些人对疫苗的安全性表示担忧（特别是血栓和中风的风险），一些人对接种第二剂疫苗犹豫不决。社会和个人利益是接种疫苗的动机。对于经历过中风或 TIA 的人来说，他们对 COVID-19 相关并发症的风险存在不确定性和缺乏信息。
尽管第一剂疫苗的接种率很高，但一些中风和 TIA 患者有合理的担忧和信息需求，这些需求应该得到解决。我们的研究结果可以用于确定特定于中风/TIA 患者的行为改变目标，以提高疫苗接种率。
